What Are Counterfeit Medicines?
The definition of a counterfeit medicine is not well established. In 1992, the WHO defined a counterfeit medicine as: “a medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source." Under this definition, it is the deliberate mislabeling of a drug or medicine which makes it a counterfeit. The US FDA uses a similar definition,
To provide some context to discussions on the term of protection for copyright and related rights, the following note sumarizes on the basic provisions in various multilateral copyright and related rights treaties, on the topics of minimum terms and formalities. … Continue Reading
Written by James Love Continue Reading
Return to KEI page on prizes to stimulate innovation
A separate page on academic and other technical papers and comments on prizes is available
here:
News Reports and Blogs on Innovation Prizes
On Saturday, KEI filed comments with the WHO EWG’s 2nd web based hearing. Our comments focused on the criteria for new proposals. Continue Reading
This paper has now been replaced by an updated version here: /prizes/cites
—————
An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes
KEI Research Note 2008:2
(Updated October 4, 2010)
2010. William Fisher and Talha Syed. Drugs, Law, and the Health Crisis in the Developing World. Stanford University Press. [link] Continue Reading
PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
KEI Research Note 2007:1
Benjamin Krohmal*
March 1, 2007
Source: EUROMEDSTAT (http://www.euromedstat.cnr.it/reports/reports_reimbursement_categories.asp)
AUSTRIA
"Heilmittelverzeichnis": Pharmaceuticals listed on the "Heilmittelverzeichnis" (Pharmaceutical List) qualify for automatic reimbursement (100%)
Continue Reading
Written by James Love
Thursday, 20 March 2008
On March 20, 2008, KEI published "Selected Innovation Prizes and Reward Programs" (cite as KEI Research Note 2008:1). The paper, which is available on the Internet here: https://www.keionline.org/misc-docs/research_notes/kei_rn_2008_1.pdf, provides the most comprehensive account of historical uses of prizes to induce innovation now available. The introduction to the 51 page report follows:
Written by James Love
Tuesday, 23 October 2007
The following are comments by experts on innovation and public health, beginning with consumer and public health groups, followed by academic experts and others.